4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-23-021308
CEO, CFO, Director gave up 1,050 shares (to pay taxes)
- CEO, CFO, Director acquired 3,475 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2023-06-12 | Option exercise | +3,475 | 7,323 | D | ||
| Finley John David CEO, CFO, Director | 2023-06-13 | Shares withheld for taxes | −1,050 | $1.54 | $1,619 | 6,273 | D |
| Derivatives | |||||||
| Finley John David CEO, CFO, Director | 2023-06-12 | Option exercise · Restricted Stock Units | −3,475 | 38,225 | D | ||
Loading xslF345X04/ownership.xml…